# Silvercrest Asset Management Group Inc.: financial statements, quarterly SAMG · Nasdaq · CIK 1549966 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/samg.md) · [Financials](/companies/samg/financials.md) · [Filings](/companies/samg/filings.md) · [Insiders](/companies/samg/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/samg/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [28.5](/filings/0000950170-25-034713.md) | [30.3](/filings/0001193125-26-108402.md) | [31.0](/filings/0001193125-26-108402.md) | [30.4](/filings/0001193125-26-108402.md) | [32.0](/filings/0001193125-26-108402.md) | [31.4](/filings/0001193125-26-216832.md) | [30.7](/filings/0001193125-26-326191.md) | [31.3](/filings/0001193125-26-437873.md) | [32.0](/filings/0001193125-26-108402.md) | [31.4](/filings/0001193125-26-216832.md) | [30.8](/filings/0001193125-26-326191.md) | [32.7](/filings/0001193125-26-437873.md) | | Operating income | $m | [(1.0)](/filings/0000950170-25-034713.md) | [5.9](/filings/0001193125-26-108402.md) | [5.3](/filings/0001193125-26-108402.md) | [4.5](/filings/0001193125-26-108402.md) | [2.0](/filings/0001193125-26-108402.md) | [4.8](/filings/0001193125-26-216832.md) | [4.0](/filings/0001193125-26-326191.md) | [1.3](/filings/0001193125-26-437873.md) | [(0.9)](/filings/0001193125-26-108402.md) | [1.3](/filings/0001193125-26-216832.md) | [1.0](/filings/0001193125-26-326191.md) | [1.9](/filings/0001193125-26-437873.md) | | Interest expense | $m | [0.1 d](/filings/0000950170-24-027981.md) | [0.1](/filings/0000950170-24-052155.md) | [0.0](/filings/0000950170-24-089297.md) | [0.0](/filings/0001193125-25-259049.md) | [0.0 d](/filings/0001193125-26-108402.md) | [0.0](/filings/0001193125-26-216832.md) | [0.0](/filings/0001193125-26-326191.md) | [0.0](/filings/0001193125-26-437873.md) | [0.1 d](/filings/0001193125-26-108402.md) | [0.2](/filings/0001193125-26-216832.md) | [0.2](/filings/0001193125-26-326191.md) | [0.2](/filings/0001193125-26-437873.md) | | Income tax | $m | [0.2 d](/filings/0001193125-26-108402.md) | [1.3](/filings/0000950170-25-067211.md) | [1.2](/filings/0000950170-25-100929.md) | [1.1](/filings/0001193125-25-259049.md) | [1.0 d](/filings/0001193125-26-108402.md) | [1.2](/filings/0001193125-26-216832.md) | [1.1](/filings/0001193125-26-326191.md) | [0.4](/filings/0001193125-26-437873.md) | [0.4 d](/filings/0001193125-26-108402.md) | [0.5](/filings/0001193125-26-216832.md) | [0.5](/filings/0001193125-26-326191.md) | [0.6](/filings/0001193125-26-437873.md) | | Net income | $m | [(0.4)](/filings/0000950170-25-034713.md) | [3.0](/filings/0001193125-26-108402.md) | [2.7](/filings/0001193125-26-108402.md) | [2.3](/filings/0001193125-26-108402.md) | [1.6](/filings/0001193125-26-108402.md) | [2.5](/filings/0001193125-26-216832.md) | [1.9](/filings/0001193125-26-326191.md) | [0.6](/filings/0001193125-26-437873.md) | [(0.1)](/filings/0001193125-26-108402.md) | [0.2](/filings/0001193125-26-216832.md) | [0.2](/filings/0001193125-26-326191.md) | [0.6](/filings/0001193125-26-437873.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0000950170-25-034713.md) | [0.32](/filings/0001193125-26-108402.md) | [0.28](/filings/0001193125-26-108402.md) | [0.24](/filings/0001193125-26-108402.md) | [0.17](/filings/0001193125-26-108402.md) | [0.26](/filings/0001193125-26-216832.md) | [0.21](/filings/0001193125-26-326191.md) | [0.07](/filings/0001193125-26-437873.md) | [(0.01)](/filings/0001193125-26-108402.md) | [0.03](/filings/0001193125-26-216832.md) | [0.02](/filings/0001193125-26-326191.md) | [0.08](/filings/0001193125-26-437873.md) | | Basic EPS | $ per share | [(0.05)](/filings/0000950170-25-034713.md) | [0.32](/filings/0001193125-26-108402.md) | [0.28](/filings/0001193125-26-108402.md) | [0.24](/filings/0001193125-26-108402.md) | [0.17](/filings/0001193125-26-108402.md) | [0.26](/filings/0001193125-26-216832.md) | [0.21](/filings/0001193125-26-326191.md) | [0.07](/filings/0001193125-26-437873.md) | [(0.01)](/filings/0001193125-26-108402.md) | [0.03](/filings/0001193125-26-216832.md) | [0.02](/filings/0001193125-26-326191.md) | [0.08](/filings/0001193125-26-437873.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [70.3](/filings/0000950170-25-034713.md) | [39.7](/filings/0000950170-24-052155.md) | [49.9](/filings/0000950170-24-089297.md) | [58.1](/filings/0000950170-24-119567.md) | [68.6](/filings/0001193125-26-108402.md) | [36.3](/filings/0000950170-25-067211.md) | [30.0](/filings/0000950170-25-100929.md) | [36.1](/filings/0001193125-25-259049.md) | [44.1](/filings/0001193125-26-437873.md) | [11.6](/filings/0001193125-26-216832.md) | [20.7](/filings/0001193125-26-326191.md) | [27.8](/filings/0001193125-26-437873.md) | | Total assets | $m | [200](/filings/0000950170-25-034713.md) | [170](/filings/0000950170-24-052155.md) | [178](/filings/0000950170-24-089297.md) | [184](/filings/0000950170-24-119567.md) | [194](/filings/0001193125-26-108402.md) | [160](/filings/0000950170-25-067211.md) | [153](/filings/0000950170-25-100929.md) | [158](/filings/0001193125-25-259049.md) | [167](/filings/0001193125-26-437873.md) | [133](/filings/0001193125-26-216832.md) | [140](/filings/0001193125-26-326191.md) | [146](/filings/0001193125-26-437873.md) | | Total liabilities | $m | [77.8](/filings/0000950170-25-034713.md) | [48.1](/filings/0000950170-24-052155.md) | [54.1](/filings/0000950170-24-089297.md) | [61.3](/filings/0000950170-24-119567.md) | [74.7](/filings/0001193125-26-108402.md) | [43.2](/filings/0000950170-25-067211.md) | [52.8](/filings/0000950170-25-100929.md) | [64.1](/filings/0001193125-25-259049.md) | [81.7](/filings/0001193125-26-437873.md) | [52.4](/filings/0001193125-26-216832.md) | [62.1](/filings/0001193125-26-326191.md) | [69.7](/filings/0001193125-26-437873.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [82.7](/filings/0000950170-25-034713.md) | [83.9](/filings/0000950170-24-052155.md) | [85.3](/filings/0000950170-24-089297.md) | [84.6](/filings/0000950170-24-119567.md) | [80.7](/filings/0001193125-26-108402.md) | [80.0](/filings/0000950170-25-067211.md) | [64.6](/filings/0000950170-25-100929.md) | [58.9](/filings/0001193125-25-259049.md) | [50.3](/filings/0001193125-26-437873.md) | [46.9](/filings/0001193125-26-216832.md) | [46.0](/filings/0001193125-26-326191.md) | [45.5](/filings/0001193125-26-437873.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [14.7 d](/filings/0001193125-26-108402.md) | [(24.1)](/filings/0000950170-25-067211.md) | [16.0 d](/filings/0000950170-25-100929.md) | [13.3 d](/filings/0001193125-25-259049.md) | [16.4 d](/filings/0001193125-26-108402.md) | [(24.7)](/filings/0001193125-26-216832.md) | [13.8 d](/filings/0001193125-26-326191.md) | [14.6 d](/filings/0001193125-26-437873.md) | [14.9 d](/filings/0001193125-26-108402.md) | [(30.7)](/filings/0001193125-26-216832.md) | [14.0 d](/filings/0001193125-26-326191.md) | [12.5 d](/filings/0001193125-26-437873.md) | | Capital expenditure | $m | [0.5 d](/filings/0001193125-26-108402.md) | [0.6](/filings/0000950170-25-067211.md) | [0.4 d](/filings/0000950170-25-100929.md) | [0.4 d](/filings/0001193125-25-259049.md) | [0.4 d](/filings/0001193125-26-108402.md) | [0.4](/filings/0001193125-26-216832.md) | [0.5 d](/filings/0001193125-26-326191.md) | [0.8 d](/filings/0001193125-26-437873.md) | [2.0 d](/filings/0001193125-26-108402.md) | [0.6](/filings/0001193125-26-216832.md) | [0.6 d](/filings/0001193125-26-326191.md) | [2.0 d](/filings/0001193125-26-437873.md) | | Dividends paid | $m | [1.8 d](/filings/0001193125-26-108402.md) | [1.8](/filings/0000950170-25-067211.md) | [1.8 d](/filings/0000950170-25-100929.md) | [1.9 d](/filings/0001193125-25-259049.md) | [1.9 d](/filings/0001193125-26-108402.md) | [1.9](/filings/0001193125-26-216832.md) | [1.8 d](/filings/0001193125-26-326191.md) | [1.7 d](/filings/0001193125-26-437873.md) | [1.7 d](/filings/0001193125-26-108402.md) | [1.6](/filings/0001193125-26-216832.md) | [1.6 d](/filings/0001193125-26-326191.md) | [1.6 d](/filings/0001193125-26-437873.md) | | Share repurchases | $m | [0.0 d](/filings/0001193125-26-108402.md) | not reported | not reported | [1.4 d](/filings/0001193125-25-259049.md) | [3.3 d](/filings/0001193125-26-108402.md) | [3.9](/filings/0001193125-26-216832.md) | [15.1 d](/filings/0001193125-26-326191.md) | [4.5 d](/filings/0001193125-26-437873.md) | [7.0 d](/filings/0001193125-26-108402.md) | [1.9](/filings/0001193125-26-216832.md) | [0.0 d](/filings/0001193125-26-326191.md) | [0.0 d](/filings/0001193125-26-437873.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | thousands of shares | [9,369](/filings/0000950170-25-034713.md) | [9,516](/filings/0001193125-26-108402.md) | [9,548](/filings/0001193125-26-108402.md) | [9,579](/filings/0001193125-26-108402.md) | [9,487](/filings/0001193125-26-108402.md) | [9,619](/filings/0001193125-26-216832.md) | [9,124](/filings/0001193125-26-326191.md) | [8,389](/filings/0001193125-26-437873.md) | [8,023](/filings/0001193125-26-108402.md) | [7,729](/filings/0001193125-26-216832.md) | [7,738](/filings/0001193125-26-326191.md) | [7,868](/filings/0001193125-26-437873.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:44 ET. No prices; not investment advice.